Preclinical and first clinical trials combining chemotherapy and anti-inflammatory drugs such as cyclooxygenase-2 (COX-2) inhibitors are already used to prevent tumor progression in prostate or breast cancer [120]. This evidence concerns the gene PTGS2 and breast cancer.